Application 210790

Type
ANDA
Sponsor
AMNEAL PHARMS CO

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001LEVOMILNACIPRAN HYDROCHLORIDELEVOMILNACIPRAN HYDROCHLORIDECAPSULE, EXTENDED RELEASE;ORALEQ 20MG BASENoNo
002LEVOMILNACIPRAN HYDROCHLORIDELEVOMILNACIPRAN HYDROCHLORIDECAPSULE, EXTENDED RELEASE;ORALEQ 40MG BASENoNo
003LEVOMILNACIPRAN HYDROCHLORIDELEVOMILNACIPRAN HYDROCHLORIDECAPSULE, EXTENDED RELEASE;ORALEQ 80MG BASENoNo
004LEVOMILNACIPRAN HYDROCHLORIDELEVOMILNACIPRAN HYDROCHLORIDECAPSULE, EXTENDED RELEASE;ORALEQ 120MG BASENoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
65162-411LevomilnacipranLevomilnacipranAmneal Pharmaceuticals LLCANDACurrent
65162-411LevomilnacipranLevomilnacipranAmneal Pharmaceuticals LLCANDACurrent
65162-411LevomilnacipranLevomilnacipranAmneal Pharmaceuticals LLCANDACurrent
65162-437LevomilnacipranLevomilnacipranAmneal Pharmaceuticals LLCANDACurrent
65162-437LevomilnacipranLevomilnacipranAmneal Pharmaceuticals LLCANDACurrent
65162-437LevomilnacipranLevomilnacipranAmneal Pharmaceuticals LLCANDACurrent
65162-455LevomilnacipranLevomilnacipranAmneal Pharmaceuticals LLCANDACurrent
65162-455LevomilnacipranLevomilnacipranAmneal Pharmaceuticals LLCANDACurrent
65162-455LevomilnacipranLevomilnacipranAmneal Pharmaceuticals LLCANDACurrent
65162-960LevomilnacipranLevomilnacipranAmneal Pharmaceuticals LLCANDACurrent
65162-960LevomilnacipranLevomilnacipranAmneal Pharmaceuticals LLCANDACurrent
65162-960LevomilnacipranLevomilnacipranAmneal Pharmaceuticals LLCANDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
57965ORIG2019-03-12